phase readout
saveNCT07347548: A Trial to Investigate the Safety and Pharmacokinetics of GRT6019 in Healthy Male Participants
ACTIVE_NOT_RECRUITINGupdated 1mo ago
community read0 votes
Sponsor: Grünenthal GmbH. Phase: PHASE1. Conditions: Duchenne Muscular Dystrophy (DMD)
view source ↗
comments(0)
5-min edit window · permanent after that